A novel combination of opiates and endothelin antagonists to manage pain without any tolerance development

Journal of Cardiovascular Pharmacology

Volumn 44, Issue SUPPL. 1, 2004, Pages

  Gulati, Anil ^a,b   Bhalla, Shaifali ^a   Matwyshyn, George ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b University of Illinois at Chicago   (United States)

Author keywords

Central nervous system; Endothelin (ET); Mice; Morphine tolerance; Rats

Indexed keywords

5 DIMETHYLAMINO N (3,4 DIMETHYL 5 ISOXAZOLYL) 1 NAPHTHALENESULFONAMIDE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN RECEPTOR ANTAGONIST; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATE; MORPHINE; NALOXONE; OPIATE DERIVATIVE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN MEMBRANE; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG TOLERANCE; MALE; MOUSE; NONHUMAN; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; PROTEIN BINDING; RAT; TAIL FLICK TEST;

ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANIMALS; DANSYL COMPOUNDS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; DRUG TOLERANCE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PEPTIDES, CYCLIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTORS, OPIOID, MU; SULFUR RADIOISOTOPES; TIME FACTORS;

EID: 11144320834     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000166242.43616.c2     Document Type: Conference Paper

References (10)

1. Thorat SN, Barjavel MJ, Matwyshyn GA, Bhargava HN. Comparative effects of NG-monomethyl-L-arginine and MK-801 on the abstinence syndrome in morphine-dependent mice. Brain Res. 1994;642:153-159.
2. Trujillo KA. Cellular and molecular mechanisms of opioid tolerance and dependence: progress and pitfalls. Pain Forum. 1999;8:29-33.
3. Mayer DJ, Mao J, Holt J, Price DD. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc Natl Acad Sci U.S.A. 1999;96:7731-7736.
4. Vaccarino AL, Kastin AJ. Endogenous opiates: 2000. Peptides. 2001;22:2257-2328.
5. Van Ree JM, Gerritis MAFM, Vanderschuren LJMJ. Opioids, reward and addiction: an encounter of biology, psychology, and medicine. Pharmacol Rev. 1999;51:342-396.
6. Rothman RB. A review of the role of anti-opioid peptides in morphine tolerance and dependence. Synapse. 1992;12:129-138.
7. Bhalla S, Matwyshyn G, Gulati A. Potentiation of morphine analgesia by BQ123, an endothelin antagonist. Peptides. 2002;23:1837-1845.
8. Gulati A, Bhargava HN. Cerebral cortical 5-HT1 and 5-HT2 receptors of morphine tolerant-dependent rats. Neuropharmacology. 1988;27:1231-1237.
9. Narita M, Mizoguchi H, Nagase H, Suzuki T, Tseng LF. Up-regulation of spinal mu-opioid receptor function to activate G-protein by chronic naloxone treatment. Brain Res. 2001;913:170-173.
10. Foley KM. Handbook of experimental pharmacology. Berlin: Springer-Verlag; 1993, 697-743.